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Methods and Results To determine if the failure to lyse pulmonary thromboemboli is caused by the local expression of the primary inhibitor of tissue-type plasminogen activator (type 1 plasminogen activator inhibitor, PAI-1), levels of PAI-1 antigen and mRNA were analyzed by immunohistochemistry and in situ hybridization in specimens harvested from a series of patients during pulmonary thromboendarterectomies. Red, fibrin-rich thrombi within the thromboendarterectomy specimens were lined with a single layer of endothelial cells exhibiting high levels of PAI-1 antigen. Quantitation of the in situ hybridization signal revealed that a significant increase in PAI-1 mRNA was present in the endothelial cells lining the fresh thrombi in comparison to the signal present in the endothelial cells from noninvolved areas of patients' pulmonary arteries (n=16, P<.001). In contrast, tissue-type plasminogen activator antigen levels were low in all samples. Yellowish-white thrombi were composed of smooth muscle cells and endothelial cells in numerous vessels that stained prominently for PAI-1 antigen. Both types of cells within the highly organized tissues also exhibited elevated PAI-1 mRNA levels in comparison to patient pulmonary artery specimens that were free of thrombus (n= 16, P<.02).
Conclusions
The prevalence of PAI-1 expression within pulmonary thromboemboli suggests that this inhibitor may play a role in the stabilization of vascular thrombi. (Circulation. 1994;89:2715-2721.)
Key Words * thrombosis * fibrinolysis * plasminogen C linical studies of acute pulmonary embolism have indicated that embolic vascular obstruction resolves in the majority of cases and results in the restoration of normal pulmonary hemodynamics.'-" However, the acute emboli fail to resolve in a small percentage of patients (currently estimated to be 0.01%).12 If obstruction is extensive, chronic thromboembolic pulmonary hypertension is the consequence. Pathologically, chronic thromboembolic pulmonary hypertension can be distinguished from primary pulmonary hypertension by the unique presence of thrombi in the segmental and/or larger-size elastic pulmonary arteries.13"14 The embolic obstructions undergo an aberrant and poorly understood process of organization and recanalization that leads to an increased right ventricular workload and, ultimately, to right ventricular failure. 15 Untreated, this disorder carries a high mortality. 15 tCells luminal to internal elastic lamina that replace the endothelial lining of the pulmonary artery.
Methods Subjects
Patients undergoing pulmonary thromboendarterectomy at the University of California San Diego Medical Center between September 1989 and December 1991 were entered into the study. The diagnosis in each patient was confirmed by careful review of the medical history, measurement of pulmonary vascular resistance, pulmonary angiography, and angioscopy. For quantitative analysis, the signal for PAI-1 mRNA was determined in cells within the thrombi of 16 consecutive patients who had provided informed consent and was compared with the PAI-1 mRNA signal in involved and noninvolved areas of the patients' pulmonary arteries as well as to the PAI-1 antigen levels in the patients' plasmas. The distribution of age, sex, duration of disease, and preoperative and postoperative pulmonary vascular resistance was similar to those in larger series that we have described previously.'2 All patients experienced a dramatic decrease in pulmonary vascular resistance as documented 3 days after the surgical intervention, when all patients were off mechanical ventilation and off vasoactive drugs, just before removal of monitoring catheters (Table) . During trimming of the pulmonary artery at the end of the pulmonary thromboendarterectomy, specimens were harvested from pulmonary arteries that were free of thrombus (noninvolved specimens) and from areas that were underlying the excised thrombus (involved specimens). The thrombi and tissues were fixed for 20 hours in paraformaldehyde (4% wtlvol in 0.1 mol/L sodium phosphate) at 4°C, embedded in paraffin blocks, and sectioned at 2-gm thickness using a microtome. The sections were mounted onto polylysine-coated slides and stored at room temperature until analyzed. For comparative purposes, blood and tissues were also obtained from heart or lung transplant organ donors at the time of explantation (n= 15). Individuals from this latter group had been selected as organ donors based on criteria that are currently used in our institution36 and include a noneventful previous medical history, normal findings on cardiac echocardiography, normal chemical analysis of blood and urine before the transplantation, and normal hemodynamics. More specifically, blood pressure of the 15 donors was 123.4+22.8/ 71± 12.1 mm Hg; heart rate, 84.7+ 15.5 beats per minute; central venous pressure, 6 .9+3.1 mm Hg; systolic pulmonary pressure, 25 .4+4.1 mm Hg; and mean pulmonary pressure, 14.1±2.8 mm Hg (all data obtained at the time of organ explantation, mean+SD). In addition, normal plasma levels for TPA and PAI-131 were ascertained in these subjects. The experimental protocol for this study was approved by the University of California, San Diego, Human Subject Investigations Committee (protocol 89-509).
Analysis of TPA and PAI-1 in Plasma Samples
Patient whole blood was collected from an arterial line into polypropylene tubes containing 200 mmol/L ethylenediaminetetraacetate (final concentration, 20 mmol/L) between 7 AM and 9 AM on the day of surgery before induction of anesthesia. Donor blood was collected 1 hour before organ explantation.
Blood was centrifuged (680g, 15 minutes, 4°C), and plateletpoor plasma was harvested and stored at -80°C. Plasma TPA antigen and PAI-1 antigen were quantitated using two-site immunoassays.31,37 PAI-1 activity was quantitated in a functional immunoassay.37,38 Standard curves for this assay were prepared using purified human PAI-1 that was reactivated by treatment with guanidine hydrochloride (37°C) followed by extensive dialysis against phosphate-buffered saline (4°C) and stored at -80°C in 30-,L aliquots. This preparation was calibrated using the International Standard TPA (83/517;
Histochemistry
Immunohistochemical staining was carried out using a three-step avidin-biotin-peroxidase method as described in detail previously.39 In this procedure, sections of paraffinembedded, paraformaldehyde-fixed tissues were incubated with either rabbit antibodies (eg, anti-von Willebrand factor [vWF]39; anti-PAI-14041l anti-TPA, American Diagnostica, Inc) or mouse monoclonal antibodies (eg, anti-human smooth muscle-a actin, clone 1A4; anti-human monocyte/macrophage, CD68, clone KPI, Dako Corp) followed by the appropriate second antibody (ie, biotinylated goat anti-rabbit IgG or biotinylated goat anti-mouse IgG, Zymed Lab). Subsequent incubations included a streptavidin-peroxidase conjugate followed with the chromogen aminoethylcarbazole/hydrogen peroxide mixture (Zymed Lab) that results in a reddish-brown deposit indicative of positive immuinoreactivity. To differentiate fresh thrombus from organized thrombus and to identify fibrin/fibrinogen and collagen, a l:richrome stain was performed according to published procedures. 42 In Situ Hybridization A PAI-1 cDNA fragment containing nucleotides 1 to 1085 in pGEM-3Z (Promega Corp) was used for the preparation of antisense and sense riboprobes by ijn vitro transcription using SP6 RNA polymerase or T7 RNA polymerase, respectively, in the presence of 35S-UTP (specific activity, 1200 Ci/mmol, Amersham) as described previously.34'39 The riboprobe was purified and used to detect PAI-1 mRNA on paraffin sections using the in situ hybridization prolocols described in detail previously.34'39 After in situ hybridization of the 35S-labeled antisense probe with the tissue sections, the slides were coated with Kodak NTB2 emulsion and exposed in the dark at 4°C for 10 weeks. Slides were developed for 2 minutes in Kodak D19 developer, fixed, washed, and counterstained with hematoxylin and eosin, which stains the nuclei blue. Parallel sections were analyzed using a sense probe as the control for nonspecific hybridization, and in no instance was, a specific signal detected even after 12 weeks of exposure. Specimens were analyzed using combined light/epiluminescence microscopy to permit a simultaneous visualization of the saimple and exposed silver grains. The latter appear as black or green dots, depending on illumination, and indicate the presence of PAI-1 mRNA.
Statistical Analysis
Quantitation of the in situ hybridization signal was done by counting silver grains associated with >200 nucleated cells at either a x 400 or x 1000 magnification using oil immersion. Data are expressed as exposed silver grains per 100 nuclei. A mean count of <60 silver grains per 100 nuclei was found in control pulmonary artery endothelial cells and <120 silver grains per 100 nuclei in control puJlmonary artery smooth muscle cells. Because the data were not in a Gaussian distribution, differences were assessed with the use of the MannWhitney test.43 Furthermore, the mean numbers of grains per 100 nuclei were correlated with levels of PAI-1 in the patients' plasmas using a Spearman's rank coefficient.43 Differences were considered significant at P<.05.
Results
The majority of the thrombi were composed of fresh red material and yellowish-white organized tissue (Fig  la) . Fresh thrombus was not only found superimposed on organized clot (Fig la) , but an abundance of fibrin and red blood cells could also be detected within vascular lumina in the organized tissue by using a trichrome stain (Fig lb) . This technique results in a reddish-blue stain in the presence of fibrin/fibrinogen (Fig lc) , whereas collagen is stained green. Immunohistochemical analyses of parallel sections revealed that the surfaces of these fresh clots were covered by vWF antigen-positive cells (Fig ld, high magnification of Fig  lb, arrow) . Some parts of the thrombus stained diffusely with antibodies against vWF antigen (data not shown), but this staining was at a low intensity compared with the staining of the cells lining the thrombus. In parallel sections, no immunoreactivity for macrophage-related antigen CD68 (Fig le) and a weak signal for TPA (Fig  lf) were detected. However, intense staining for PAI-1 antigen (Fig lg) and signal for PAI-1 mRNA (Fig lh) were observed in the cells that lined the surfaces of the fresh thrombi.
In comparison, low-power examinations of the organized parts of the thrombi revealed endothelialized vessels of different sizes (Fig 2a) . The parenchymal tissue was composed of cells in a collagen matrix rather than a fibrin meshwork, as revealed by the trichrome stain (Fig   2a) . The cells lining neovascular structures were identified as endothelial cells, based on their immunological reactivity toward antibodies to vWF (Fig 2b) . Although these cells stained weakly for TPA (Fig 2c) , intense staining for PAI-1 antigen was observed in nucleated cells (Fig 2d) . The spindle-shaped cells within the collagen matrix demonstrated immunoreactivity both for PAI-1 (Fig 2g) and for smooth muscle a-actin (data not shown). Analyses of the organized regions of the vascular thrombi for PAI-1 mRNA by in situ hybridization revealed a strong signal in (1) endothelial cells lining the neovessels in the thrombus (Fig 2f) and (2) the spindleshaped, smooth muscle a-actin-positive cells that constituted the thrombus parenchyma (Fig 2h) .
To obtain quantitative data on the steady-state levels of PAI-1 mRNA, we determined the mean number of exposed silver grains per 100 nuclei (Table) . No Table) . 
